These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease. Esquerda-Canals G, Martí-Clúa J, Roda AR, Villegas S. J Alzheimers Dis; 2017; 59(3):1079-1096. PubMed ID: 28697564 [Abstract] [Full Text] [Related]
27. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Walker JM, Fowler SW, Miller DK, Sun AY, Weisman GA, Wood WG, Sun GY, Simonyi A, Schachtman TR. Behav Brain Res; 2011 Sep 12; 222(1):169-75. PubMed ID: 21443906 [Abstract] [Full Text] [Related]
29. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease. Orta-Salazar E, Aguilar-Vázquez A, Martínez-Coria H, Luquín-De Anda S, Rivera-Cervantes M, Beas-Zarate C, Feria-Velasco A, Díaz-Cintra S. Life Sci; 2014 Oct 29; 116(2):83-9. PubMed ID: 25261598 [Abstract] [Full Text] [Related]
30. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease. Sui X, Ren X, Huang P, Li S, Ma Q, Ying M, Ni J, Liu J, Yang X. J Alzheimers Dis; 2014 Oct 29; 40(3):575-86. PubMed ID: 24496070 [Abstract] [Full Text] [Related]
31. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC. J Alzheimers Dis; 2010 Oct 29; 20(1):113-26. PubMed ID: 20164597 [Abstract] [Full Text] [Related]
32. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice. Lee S, Lemere CA, Frost JL, Shea TB. J Alzheimers Dis; 2012 Oct 29; 28(2):423-31. PubMed ID: 22045486 [Abstract] [Full Text] [Related]
34. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Kobayashi DT, Chen KS. Genes Brain Behav; 2005 Apr 29; 4(3):173-96. PubMed ID: 15810905 [Abstract] [Full Text] [Related]
35. Bizarre behaviors and risk assessment in 3xTg-AD mice at early stages of the disease. Baeta-Corral R, Giménez-Llort L. Behav Brain Res; 2014 Jan 01; 258():97-105. PubMed ID: 24144550 [Abstract] [Full Text] [Related]
36. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease. Dal-Pan A, Dudonné S, Bourassa P, Bourdoulous M, Tremblay C, Desjardins Y, Calon F, Neurophenols consortium. J Alzheimers Dis; 2017 Jan 01; 55(1):115-135. PubMed ID: 27662290 [Abstract] [Full Text] [Related]
38. Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains. Janus C, Flores AY, Xu G, Borchelt DR. Neurobiol Aging; 2015 Sep 01; 36(9):2519-32. PubMed ID: 26089165 [Abstract] [Full Text] [Related]
39. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice. Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW. J Neurosci Methods; 2008 Jan 30; 167(2):358-66. PubMed ID: 17904642 [Abstract] [Full Text] [Related]
40. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI. Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]